Mechanism-based in vitro screening of potential cancer chemopreventive agents

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 523-524, Issue , 2003, Pages 163-172

  Gerhäuser, Clarissa ^a   Klimo, Karin ^a   Heiss, Elke ^a,b   Neumann, Isabell ^a,c   Gamal Eldeen, Amira ^a,d   Knauft, Jutta ^a   Liu, Guang Yaw ^a,e   Sitthimonchai, Somkid ^a,f   Frank, Norbert ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c Europroteome AG   (Germany)

^d NATIONAL RESEARCH CENTRE   (Egypt)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^f CHULABHORN RESEARCH INSTITUTE   (Thailand)

Author keywords

Bioassay systems; Cancer chemoprevention; iNOS; Mechanisms; NF B; PEITC

Indexed keywords

3 INDOLEMETHANOL; ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; ASCORBIC ACID; BUTYRIC ACID; CURCUMIN; DIALLYLDISULFIDE; DIALLYLSULFIDE; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; GENISTEIN; GLYCYRRHETINIC ACID; LIMONENE; OLEANOLIC ACID; PERILLYL ALCOHOL; PHENETHYL ISOTHIOCYANATE; PICEATANNOL; PIROXICAM; QUERCETIN; RESVERATROL; SILYMARIN; TAMOXIFEN; TROLOX C; UNCLASSIFIED DRUG;

ANIMAL CELL; CANCER PREVENTION; CARCINOGENESIS; CELL STRAIN; CONFERENCE PAPER; CONTROLLED STUDY; DRUG METABOLISM; DRUG SCREENING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

MURINAE;

EID: 0037294150     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00332-9     Document Type: Conference Paper

References (23)

1. Sporn M.B., Dunlop N.M., Newton D.L., Smith J.M. Prevention of chemical carcinogenesis by Vitamin A and its synthetic analogs. Fed. Proc. 35:1976;1332-1338.
2. Kelloff G.J., Boone C.W., Steele V.E., Fay J.R., Lubet R.A., Crowell J.A., Sigman C.C. Mechanistic considerations in chemopreventive drug development. J. Cell. Biochem. Suppl. 20:1994;1-24.
3. Kelloff G.J., Boone C.W., Steele V.E., Crowell J.A., Lubet R.A., Greenwald P., Hawk E.T., Fay J.R., Sigman C.C. Mechanistic considerations in the evaluation of chemopreventive data. IARC Sci. Publ. 139:1996;203-219.
4. Greenwald P. From carcinogenesis to clinical interventions for cancer prevention. Toxicology. 166:2001;37-45.
5. Talalay P., Fahey J.W., Holtzclaw W.D., Prestera T., Zhang Y. Chemoprotection against cancer by phase 2 enzyme induction. Toxicol. Lett. 82/83:1995;173-179.
6. Halliwell B., Zhao K., Whiteman M. The gastrointestinal tract: a major site of antioxidant action? Free Radic. Res. 33:2000;819-830.
7. Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305:1994;253-264.
8. Cuendet M., Pezzuto J.M. The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metab. Drug Interact. 17:2000;109-157.
9. Thomas T., Thomas T.J. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell. Mol. Life Sci. 58:2001;244-258.
10. Crespi C.L., Miller V.P., Penman B.W. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal. Biochem. 248:1997;188-190.
11. Gerhäuser C., You M., Liu J., Moriarty R.M., Hawthorne M., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res. 57:1997;272-278.
12. van Amsterdam F.T., Roveri A., Maiorino M., Ratti E., Ursini F. Lacidipine: a dihydropyridine calcium antagonist with antioxidant activity. Free Radic. Biol. Med. 12:1992;183-187.
13. Ukeda H., Maeda S., Ishii T., Sawamura M. Spectrophotometric assay for superoxide dismutase based on tetrazolium salt 3′,1-(phenylamino)-carbonyl-3,4-tetrazolium]-bis(4-methoxy-6-nitro) benzenesulfonic acid hydrate reduction by xanthine/xanthine oxidase. Anal. Biochem. 251:1997;206-209.
14. Pick E., Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J. Immunol. Methods. 46:1981;211-226.
15. Cao G., Prior R.L. Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol. 299:1999;50-62.
16. Heiss E., Herhaus C., Klimo K., Bartsch H., Gerhäuser C. Nuclear factor-κB is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 276:2001;32008-32015.
17. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
18. Gerhäuser C., Mar W., Lee S.K., Suh N., Luo Y., Kosmeder J., Luyengi L., Fong H.H., Kinghorn A.D., Moriarty R.M., Mehta R.G., Constantinou A., Moon R.C., Pezzuto J.M. Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nat. Med. 1:1995;260-266.
19. Zinsmeister H.D., Becker H., Eicher T. Bryophytes, a source of biologically active, naturally occurring material? Angew. Chem. Int. Ed. Engl. 30:1990;130-147.
20. Gerhäuser C., Heiss E., Klimo K., Neumann I., Becker H., Eicher Th., Bartsch H. Bibenzyl derivatives as novel lead compounds in chemoprevention. Proc. Am. Assoc. Cancer Res. 41:2000;412.
21. Gerhäuser C., Alt A., Heiss E., Gamal-Eldeen A., Klimo K., Knauft J., Neumann I., Scherf H., Frank N., Bartsch H., Becker H. Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 1:2002;959-969.
22. Hecht S.S. Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. J. Nutr. 129:1999;768S-774S.
23. Kong A.N., Owuor E., Yu R., Hebbar V., Chen C., Hu R., Mandlekar S. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab. Rev. 33:2001;255-271.